Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients

BACKGROUND: The poor prognosis and minimally successful treatments of malignant glioma indicate a challenge to identify new therapeutic targets which impact glioma progression. Neurotensin (NTS) and its high affinity receptor (NTSR1) overexpression induces neoplastic growth and predicts the poor pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouyang, Qing, Gong, Xueyang, Xiao, Hualiang, Zhou, Ji, Xu, Minhui, Dai, Yun, Xu, Lunshan, Feng, Hua, Cui, Hongjuan, Yi, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351837/
https://www.ncbi.nlm.nih.gov/pubmed/25644759
http://dx.doi.org/10.1186/s12943-015-0290-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351837/
https://www.ncbi.nlm.nih.gov/pubmed/25644759
http://dx.doi.org/10.1186/s12943-015-0290-8

Ejemplares similares